ANNA KATHRYN KRAGT

Allopathic & Osteopathic Physicians|Family Medicine MIDDLEBURY, IN NPI 1003838293

General Payments — all program years on this page

$907.93

  • Category: General Payments
  • Program years: PY2018–2021
  • Record count: 63
  • As of (CMS publication): 2026-01-23

Latest program year (PY2021): $387.88 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2021) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $387.8822

By paying entity

Latest program year (PY2021) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $154.9213
2019 $194.2315
2020 $170.9013
2021 $387.8822

Records — PY2021 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
763597950 Boehringer Ingelheim Pharmaceuticals, Inc. $17.10 05/24/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
788925997 Janssen Pharmaceuticals, Inc $17.75 05/18/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
788925999 Janssen Pharmaceuticals, Inc $14.65 06/19/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
788926001 Janssen Pharmaceuticals, Inc $15.82 01/09/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
788926003 Janssen Pharmaceuticals, Inc $13.95 09/21/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
788926005 Janssen Pharmaceuticals, Inc $28.79 10/05/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
795159059 AbbVie Inc. $28.29 05/15/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
795159063 AbbVie Inc. $26.25 09/25/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
813511337 Paratek Pharmaceuticals, Inc. $15.53 06/07/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
813511341 Paratek Pharmaceuticals, Inc. $18.07 07/12/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
818432225 Abbott Laboratories $18.45 03/05/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
818944393 Lilly USA, LLC $15.95 03/09/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
821406371 Astellas Pharma US Inc $19.36 01/04/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
821406377 Astellas Pharma US Inc $18.34 06/21/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
825148261 Amgen Inc. $14.18 09/27/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
829664531 Amneal Pharmaceuticals LLC $17.67 03/05/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
830023209 AstraZeneca Pharmaceuticals LP $14.00 02/16/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
836092013 Novo Nordisk Inc $12.07 03/02/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
836092015 Novo Nordisk Inc $20.86 03/12/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
836092017 Novo Nordisk Inc $14.61 07/24/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
837430815 Xeris Pharmaceuticals, Inc. $14.49 08/16/2021 Food and Beverage Undisputed 01/23/2026 View at CMS
845285013 DEXCOM, INC. $11.70 03/15/2021 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.